Epicrispr Biotechnologies vs Latus Bio
Epicrispr Biotechnologies vs Latus Bio, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Latus Bio on 54/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 54/100
- domain rating: 40/100 against 25/100
- headcount: 51 against 27
- LinkedIn following: 7,025 against 3,459
Latus Bio
- funding raised: $151M against $90.0M
At a glance
| Measure | Epicrispr Biotechnologies | Latus Bio |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Engineering scalable gene therapies for broader patient populations. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Gene Therapy, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2020 | 2022 |
| Headquarters | South San Francisco, United States | Boston, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Latus Bio |
|---|---|---|
| Employees | 51 | 27 |
| Total funding | $90.0M | $151M |
| Latest round | Series C | Series A (Extension) |
| LinkedIn followers | 7,025 | 3,459 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Latus Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 54/100 |
| Traction | 57/100 | 54/100 |
| Team | 40/100 | 70/100 |
| Search visibility | 20/100 | 35/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 25/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Latus Bio |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs Latus Bio: common questions
Which is better, Epicrispr Biotechnologies or Latus Bio?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Latus Bio compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 54/100), domain rating (40/100 against 25/100), headcount (51 against 27), LinkedIn following (7,025 against 3,459). Latus Bio leads on funding raised ($151M against $90.0M).
Read the full Epicrispr Biotechnologies review and pricing or the Latus Bio review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.